Research Article

Evaluation of Thyroid Function in Patients Hospitalized for Acute Heart Failure

Table 4

Association between inpatient parameters and long-term clinical outcomes.

Unadjusted modelAge- and sex-adjusted model
Hazard ratio (95% CI) valueHazard ratio (95% CI) value

All-cause mortality
 TSH (μIU/mL)1.02 (0.88 to 1.19)0.7911.03 (0.88 to 1.19)0.733
 FT4 (ng/dL)1.40 (0.69 to 2.85)0.3501.22 (0.59 to 2.52)0.599
 BNP (pg/mL)1.16 (0.99 to 1.36)0.0741.16 (0.99 to 1.37)0.070
 eGFR0.99 (0.99 to 1.00)0.0150.99 (0.99 to 1.00)0.105
 LV ejection fraction (%)0.98 (0.96 to 1.01)0.1820.98 (0.96 to 1.01)0.146
 PASP (mmHg)1.03 (1.02 to 1.05)<0.0011.03 (1.02 to 1.05)<0.001

Cardiovascular mortality
 TSH (μIU/mL)1.02 (0.82 to 1.26)0.8751.02 (0.83 to 1.27)0.823
 FT4 (ng/dL)1.40 (0.53 to 3.71)0.5011.33 (0.49 to 3.58)0.577
 BNP (pg/mL)1.35 (1.08 to 1.69)0.0071.35 (1.08 to 1.70)0.009
 eGFR (mL/min/1.73 m2)1.00 (0.99 to 1.01)0.4411.00 (0.99 to 1.01)0.518
 LV ejection fraction (%)0.98 (0.95 to 1.01)0.2680.98 (0.94 to 1.01)0.200
 PASP (mmHg)1.04 (1.02 to 1.06)<0.0011.04 (1.02 to 1.06)<0.001

TSH and BNP were log-transformed. CI: confidence interval; TSH: thyroid-stimulating hormone; FT4: free thyroxine; BNP: B-type natriuretic peptide; eGFR: estimated glomerular filtration rate; LV: left ventricle; PASP: pulmonary arterial systolic pressure.